HNRNPH1 and blast phase chronic myelogenous leukemia, BCR-ABL1 positive: In the present study, we demonstrated that HNRNPH1 expression was higher in CML patients compared with healthy donors, and gradually elevated along with disease progression that blast crisis patients have significantly highly expressed HNRNPH1 (Figures 1A–C).